Richard E. Rupp

TL;DR: In this paper , an open-label clinical trial was conducted at 10 sites in the United States, where adults who had completed a Covid-19 vaccine regimen at least 12 weeks earlier and had no reported history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection received a booster injection with one of three vaccines: mRNA-1273 (Moderna) at a dose of 100 μg, Ad26.COV2.S (Johnson & Johnson-Janssen), or BNT162b2 (Pfizer-BioNTech).

TL;DR: VivaGel™ appears to be well tolerated in both animals and humans and its active ingredient, SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind.

TL;DR: VAX102 was safe and induced high antibody levels to M2e at 0.3 and 1.0 μg doses and was able to induce a fourfold rise in antibody in humans, to a previously non-immunogenic, highly-conserved portion of the influenza virus.

TL;DR: Mothers' decisions about the HPV vaccine were not related to their sexual values or their daughters' sexual behavior, but rather their parenting, sense of vulnerability, and vaccine attitudes.

TL;DR: The vaccine was generally well tolerated, although local and systemic adverse events were significantly more common in the vaccine group, and the efficacy did not reach conventional levels of significance.